Acute Effects of Rho-Kinase Inhibitor Fasudil on Pulmonary Arterial Hypertension in Patients With Congenital Heart Defects

Circulation Journal - Japan
doi 10.1253/circj.cj-14-1015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Circulation Society

Related search

Liposomal Fasudil, a Rho-Kinase Inhibitor, for Prolonged Pulmonary Preferential Vasodilation in Pulmonary Arterial Hypertension

Journal of Controlled Release
Pharmaceutical Science
2013English

Pulmonary Arterial Hypertension Associated With Congenital Heart Disease

Current Pediatrics Reports
2013English

Pulmonary Arterial Hypertension Associated With Congenital Heart Disease

2020English

Pulmonary Arterial Hypertension in Congenital Heart Disease

Continuing Cardiology Education
2018English

Focusing on Pulmonary Arterial Hypertension in Adults With Congenital Heart Disease

Advances in Pulmonary Hypertension
2007English

Tyrosine Kinase Inhibitor–Induced Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2018English

Analysis of Pulmonary Vasodilator Responses to the Rho-Kinase Inhibitor Fasudil in the Anesthetized Rat

American Journal of Physiology - Lung Cellular and Molecular Physiology
PulmonaryRespiratory MedicinePhysiologyCell Biology
2008English

Pulmonary Hypertension in Infants With Congenital Heart Defects: Are Leukotrienes Involved?

Mediators of Inflammation
ImmunologyCell Biology
1997English

Changing Demographics of Pulmonary Arterial Hypertension in Congenital Heart Disease

European Respiratory Review
PulmonaryRespiratory Medicine
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy